Pr/sub 6/Fe/sub 87/NbB/sub 6/
Cut-off value of FEV<sub>1</sub>/FEV<sub>6</sub> as a surrogate for FEV<sub>1</sub>/FVC for detecting airway obstruction in a Korean population
... /FEV 6 cut-off for predicting FEV 1 /FVC ,70% was 75% using receiver operating characteristic curve analyses (area under receiver operating char- acteristic curve .../FEV 6 showed .../FEV 6 ,75% ...
7
In vitro toxicity of Fe<sub>m</sub>O<sub>n</sub>, Fe<sub>m</sub>O<sub>n</sub>-SiO<sub>2</sub> composite, and SiO<sub>2</sub>-Fe<sub>m</sub>O<sub>n</sub> core-shell magnetic nanoparticles
... characterization, Fe m O n -SiO 2 composite flake-like and SiO 2 -Fe m O n core-shell IONPs demonstrated spherical shape with mean diameter of 98 ± 22 and 101 ± 19 nm, respectively (Figure ...2B–E). ...
11
Biocompatibility of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles and their cytotoxic effect on MCF-7 cells
... the Fe 3 O 4 , sterile normal saline was added to prepare mixed suspensions of different ...a 6-hour wait after the second injection, after which time the mice were killed by cervical vertebra ...
10
Effect of Fe<sub>3</sub>O<sub>4</sub>-magnetic nanoparticles on acute exercise enhanced KCNQ<sub>1</sub> expression in mouse cardiac muscle
... Forty-two mice were randomly assigned to either the non- exercised control group (n = 6) or exercise groups (n = 36). Thirty-six mice were placed into plastic cylinders (23 cm tall × 14 cm diameter) containing ...
8
Magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> enhance docetaxel-induced prostate cancer cell death
... (Figure 6). Combined treatment with MgNPs-Fe 3 O 4 and DTX enhanced the inhibitory effect of DTX; in PC-3 cells, 100 µ g/mL of MgNPs-Fe 3 O 4 plus 1 nM of DTX reduced cell viability so it was similar ...
10
Preparation and in vitro evaluation of doxorubicin-loaded Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles modified with biocompatible copolymers
... the Fe 3 O 4 -PLGA-PEG nanoparticles was also pH-dependent and enhanced at pH ...about 6 days, we can consider that drug is released from the Fe 3 O 4 -PLGA-PEG nanoparticles by a diffusion mechanism ...
16
Preparation of Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles coated with gallic acid for drug delivery
... Transmission electron microscopy of the magnetic iron oxide nanoparticles and iron oxide nanoparticles coated with chitosan and gallic acid was performed to determine the shape, size, and uniformity of the particles ...
12
The effect of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> on immune function in normal ICR mice
... whether Fe 3 O 4 -MNPs can alter cytokine production patterns in peripheral blood, enzyme-linked immunosorbent assay was ...conducted. Fe 3 O 4 -MNPs altered the production of IL-2, INF- γ , and ...of ...
7
The effects of magnetite (Fe<sub>3</sub>O<sub>4</sub>) nanoparticles on electroporation-induced inward currents in pituitary tumor (GH<sub>3</sub>) cells and in RAW 264.7 macrophages
... of Fe 3 O 4 NPs on I MEP , we studied whether the nanoparticles could alter the I MEP measured at the different levels of membrane potentials in these ...of Fe 3 O 4 ...to Fe 3 O 4 NPs (100 µ g/mL) ...
10
Polyetherimide-grafted Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticles as theranostic agents for simultaneous VEGF siRNA delivery and magnetic resonance cell imaging
... 60%. Fe 3 O 4 @SiO 2 /PEI, Fe 3 O 4 @SiO 2 / PEI/Sc shRNA, or Fe 3 O 4 @SiO 2 /PEI/VEGF shRNA was incubated with the cells in serum-free medium for 6 hours, and then replaced with complete ...
13
Biosafety evaluation of Janus Fe<sub>3</sub>O<sub>4</sub>-TiO<sub>2</sub> nanoparticles in Sprague Dawley rats after intravenous injection
... All animals were kept in stress-free, hygienic, and animal- friendly conditions (relative humidity 60% ± 10%, room tem- perature 20 ° C ± 2 ° C, and 12-hour light/dark cycle). Food and water were available ad libitum. ...
15
Biological responses to core–shell-structured Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-NH<sub>2</sub> nanoparticles in rats by a nuclear magnetic resonance-based metabonomic strategy
... for Fe@Si NP intravenous adminis- tration: control group, low-dose 10 nm Fe@Si NP-exposure group (10L), low-dose 20 nm Fe@Si NP-exposure group (20L), high-dose 20 nm Fe@Si NP-exposure group ...
16
The changes of T lymphocytes and cytokines in ICR mice fed with Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles
... with Fe 3 O 4 magnetic nanoparticles (Fe 3 O 4 -MNPs). The Fe 3 O 4 -MNPs were synthesized, and their characteristics such as particle size, zeta potential, and X-ray diffraction patterns were ...
6
Synthesis of composite magnetic nanoparticles Fe<sub>3</sub>O<sub>4</sub> with alendronate for osteoporosis treatment
... of Fe 3 O 4 , Dex/Fe 3 O 4 , and Bis/Dex/Fe 3 O 4 was verified by XRD (Figure ...standard Fe 3 O 4 pattern published by ...Bis/Dex/ Fe 3 O 4 was smaller than that of Fe 3 O 4 ...
12
Fe<sub>3</sub>O<sub>4</sub>/Au magnetic nanoparticle amplification strategies for ultrasensitive electrochemical immunoassay of alfa-fetoprotein
... the Fe 3 O 4 /Au nanocarrier, the ratio of HRP and Ab 2 is the most important factor in the response ...per Fe 3 O 4 /Au nanocarrier, which would be expected to increase the response amplification for this ...
11
Synergistic effect of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> with gambogic acid on apoptosis of K562 leukemia cells
... The morphological changes of K562 cells by optical micro- scope were shown in Figure 4. K562 cells in control group displayed normal, healthy shape demonstrated by the clear skeletons (Figure 4A); After treatment with ...
9
Biocompatibility of Fe<sub>3</sub>O<sub>4</sub>/DNR magnetic nanoparticles in the treatment of hematologic malignancies
... Blood was obtained from healthy rabbits and anticoagulated with potassium oxalate, at a final concentration of 1.0 mg/mL of blood. The Fe 3 O 4 -MNPs/DNR were scrubbed with distilled water twice, lixiviated with ...
6
In vitro and in vivo targeting imaging of pancreatic cancer using a Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoprobe modified with anti-mesothelin antibody
... (2, 6, and 24 ...applications. Fe is an essential element for human body; for example, it mediates the formation of hemoglobin and myo- hemoglobin and also associates with the activity of specific ...
13
Vancomycin-modified Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>@Ag microflowers as effective antimicrobial agents
... Van/ Fe 3 O 4 @SiO 2 @Ag microflowers decreased by ∼ 60% for ...only Fe 3 O 4 @SiO 2 @Ag ...vancomycin-modified Fe 3 O 4 @SiO 2 @Ag microflowers against resistant strains such as MRSA pro- vides a ...
18
Biocompatibility of Fe<sub>3</sub>O<sub>4</sub>@Au composite magnetic nanoparticles in vitro and in vivo
... of Fe 3 O 4 -MNPs was about 20 nm. After modification of the Fe 3 O 4 -MNPs with gold shell, the average diameter of the resulting core–shell Fe 3 O 4 @Au composite MNPs was about 35 nm, with a ...
15